Abstract
Objective
Transarterial Radioembolization (TARE) with 90Y-loaded glass microspheres is a locoregional treatment option for Hepatocellular Carcinoma (HCC). Post-treatment 90Y bremsstrahlung imaging using Single-Photon Emission Tomography (SPECT) is currently a gold-standard imaging modality for quantifying the delivered dose. However, the nature of bremsstrahlung photons causes difficulty for dose estimation using SPECT imaging. This work aimed to investigate the possibility of using glass microspheres loaded with 90Y and Nanoparticles (NPs) to improve the quantification of delivered doses.
Methods
The Monte Carlo codes were used to simulate the post-TARE 90Y planar imaging. Planar images from bremsstrahlung photons and characteristic X-rays are acquired when 0, 1.2 mol/L, 2.4 mol/L, and 4.8 mol/L of Gold (Au), Hafnium (Hf), and Gadolinium (Gd) NPs are incorporated into the glass microspheres. We evaluated the quality of acquired images by calculating sensitivity and Signal-to-Background Ratio (SBR). Therapeutic effects of NPs were evaluated by calculation of Dose Enhancement Ratio (DER) in tumoral and non-tumoral liver tissues.
Results
The in silico results showed that the sensitivity values of bremsstrahlung and characteristic X-ray planar images increased significantly as the NPs concentration increased in the glass microspheres. The SBR values decreased as the NPs concentration increased for the bremsstrahlung planar images. In contrast, the SBR values increased for the characteristic X-ray planar images when Hf and Gd were incorporated into the glass microspheres. The DER values decreased in the tumoral and non-tumoral liver tissues as the NPs concentration increased. The maximum dose reduction was observed at the NPs concentration of 4.8 mol/L (≈ 7%).
Conclusions
The incorporation of Au, Hf, and Gd NPs into the glass microspheres improved the quality and quantity of post-TARE planar images. Also, treatment efficiency was decreased significantly at NPs concentration > 4.8 mol/L.
Similar content being viewed by others
References
McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4–13.
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7(1):6.
Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, et al. Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline. J Clin Oncol. 2020;38(36):4317–45.
Li R, Li D, Jia G, Li X, Sun G, Zuo C. Diagnostic performance of theranostic radionuclides used in transarterial radioembolization for liver cancer. Front Oncol. 2021;10:551622.
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.
Hall JE, Hall ME. Guyton and hall textbook of medical physiology e-book. New York: Elsevier Health Sciences; 2020.
Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985;89(2):279–86.
Saini A, Wallace A, Alzubaidi S, Knuttinen MG, Naidu S, Sheth R, et al. History and evolution of yttrium-90 radioembolization for hepatocellular carcinoma. J Clin Med. 2019;8(1):55.
Eaton BR, Kim HS, Schreibmann E, Schuster DM, Galt JR, Barron B, et al. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma. J Vasc Interv Radiol. 2014;25(2):288–95.
Mikell JK, Mahvash A, Siman W, Baladandayuthapani V, Mourtada F, Kappadath SC. Selective internal radiation therapy with yttrium-90 glass microspheres: biases and uncertainties in absorbed dose calculations between clinical dosimetry models. Int J Radiat Oncol Biol Phys. 2016;96(4):888–96.
Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions–radionuclide S values at the voxel level. Medical internal radiation dose committee. J Nucl Med. 1999;40(1):11–36.
Rong X, Du Y, Ljungberg M, Rault E, Vandenberghe S, Frey EC. Development and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method. Med Phys. 2012;39(5):2346–58.
Shiba H, Takahashi A, Baba S, Himuro K, Yamashita Y, Sasaki M. Analysis of the influence of (111)In on (90)Y-bremsstrahlung SPECT based on Monte Carlo simulation. Ann Nucl Med. 2016;30(10):675–81.
Uribe CF, Esquinas PL, Gonzalez M, Celler A. Characteristics of Bremsstrahlung emissions of (177)Lu, (188)Re, and (90)Y for SPECT/CT quantification in radionuclide therapy. Phys Med. 2016;32(5):691–700.
Siddique S, Chow JCL. Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials (Basel). 2020;10(9):1700.
Sajo E, Zygmanski P. Nanoparticle enhanced radiation therapy; principles, methods and applications. Bristol: IOP Publishing; 2020. https://doi.org/10.1088/978-0-7503-2396-3.
Pratt EC, Shaffer TM, Zhang Q, Drain CM, Grimm J. Nanoparticles as multimodal photon transducers of ionizing radiation. Nat Nanotechnol. 2018;13(5):418–26.
Jan S, Santin G, Strul D, Staelens S, Assié K, Autret D, et al. GATE: a simulation toolkit for PET and SPECT. Phys Med Biol. 2004;49(19):4543–61.
Philips Healthcare. Patients first performance: Philips BrightView SPECT specification. Gurgaon: Philips Healthcare; 2013.
Chauvie S, Guatelli S, Ivanchenko V, Longo F, Mantero A, Mascialino B, et al. Geant4 low energy electromagnetic physics. IEEE Symp Conf Record Nucl Sci. 2004;2004:16–22.
Ryu H, Meikle SR, Willowson KP, Eslick EM, Bailey DL. Performance evaluation of quantitative SPECT/CT using NEMA NU 2 PET methodology. Phys Med Biol. 2019;64(14):145017.
Sangro B, Iñarrairaegui M, Bilbao JI. Radioembolization for hepatocellular carcinoma. J Hepatol. 2012;56(2):464–73.
Deslattes RD, Kessler EG, Indelicato P, de Billy L, Lindroth E, Anton J. X-ray transition energies: new approach to a comprehensive evaluation. Rev Mod Phys. 2003;75(1):35–99.
Seltzer SM. Cross sections for bremsstrahlung production and electron-impact ionization. In: Jenkins TM, Nelson WR, Rindi A, editors. Monte Carlo transport of electrons and photons. Boston: Springer; 1988. p. 81–114.
Wong FC. MIRD: radionuclide data and decay schemes. J Nucl Med. 2009;50(12):2091.
Agostinelli S, Allison J, Amako K, Apostolakis J, Araujo H, Arce P, et al. Geant4—a simulation toolkit. Nucl Instrum Methods Phys Res Sect. 2003;506(3):250–303.
Segars WP, Tsui BMW, Jing C, Fang-Fang Y, Fung GSK, Samei E. Application of the 4-D XCAT phantoms in biomedical imaging and beyond. IEEE Trans Med Imaging. 2018;37(3):680–92.
Siman W, Mikell JK, Kappadath SC. Practical reconstruction protocol for quantitative (90)Y bremsstrahlung SPECT/CT. Med Phys. 2016;43(9):5093.
Haliloğlu R, Karadeniz Ö, Durak H. A study on the extrinsic sensitivity and counting efficiency of a gamma camera for a cylindrical source and a rectangular detector. Appl Radiat Isot. 2017;130:218–23.
Rabus H, Li WB, Villagrasa C, Schuemann J, Hepperle PA, de la Fuente RL, et al. Intercomparison of Monte Carlo calculated dose enhancement ratios for gold nanoparticles irradiated by X-rays: assessing the uncertainty and correct methodology for extended beams. Phys Med. 2021;84:241–53.
Huey OS, See YJ, Nabila S, Ping HS, Suzanah I. Collimator and energy window optimization for practical imaging protocol and quantification of Yttrium-90 bremsstrahlung spect/ct: a phantom study. Radiat Phys Chem. 2021;178:109080.
Kim M, Bae JK, Hong BH, Kim KM, Lee W. Effects of collimator on imaging performance of Yttrium-90 Bremsstrahlung photons: Monte Carlo simulation. Nucl Eng Technol. 2019;51(2):539–45.
İnce C, Karadeniz Ö, Ertay T, Durak H. Collimator and energy window optimization for YTTRIUM-90 bremsstrahlung SPECT imaging. Appl Radiat Isot. 2021;167:109453.
Villalobos A, Soliman MM, Majdalany BS, Schuster DM, Galt J, Bercu ZL, et al. Yttrium-90 radioembolization dosimetry: what trainees need to know. Semin Intervent Radiol. 2020;37(5):543–54.
Walrand S, Hesse M, Wojcik R, Lhommel R, Jamar F. Optimal design of anger camera for bremsstrahlung imaging: monte carlo evaluation. Front Oncol. 2014;4:149.
Hamilton DI. Diagnostic nuclear medicine: a physics perspective. Berlin: Springer Science & Business Media; 2004.
Roshan HR, Mahmoudian B, Gharepapagh E, Azarm A, Pirayesh IJ. Collimator and energy window optimization for 90Y bremsstrahlung SPECT imaging: a SIMIND Monte Carlo study. Appl Radiat Isot. 2016;108:124–8.
Sukhanova A, Bozrova S, Sokolov P, Berestovoy M, Karaulov A, Nabiev I. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett. 2018;13(1):44.
Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25(Suppl 1):S41-55.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Talebi, A.S., Rajabi, H. & Watabe, H. Role of nanoparticles in transarterial radioembolization with glass microspheres. Ann Nucl Med 36, 479–487 (2022). https://doi.org/10.1007/s12149-022-01727-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-022-01727-7